Stem Cell Therapy against Ischemic Heart Disease
International Journal of Molecular Sciences · 28.03.2024 · 25 (7) · 3778
DOI: 10.3390/ijms25073778 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 28.03.2024. Verfasst von I-Ting Tsai und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung City 82445, Taiwan. Hauptthemen laut MEDLINE: Myocardial Ischemia, Myocardial Infarction, Induced Pluripotent Stem Cells. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 193 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Ischemic heart disease, which is one of the top killers worldwide, encompasses a series of heart problems stemming from a compromised coronary blood supply to the myocardium. The severity of the disease ranges from an unstable manifestation of ischemic symptoms, such as unstable angina, to myocardial death, that is, the immediate life-threatening condition of myocardial infarction. Even though patients may survive myocardial infarction, the resulting ischemia-reperfusion injury triggers a cascade of inflammatory reactions and oxidative stress that poses a significant threat to myocardial function following successful revascularization. Moreover, despite evidence suggesting the presence of cardiac stem cells, the fact that cardiomyocytes are terminally differentiated and cannot significantly regenerate after injury accounts for the subsequent progression to ischemic cardiomyopathy and ischemic heart failure, despite the current advancements in cardiac medicine. In the last two decades, researchers have realized the possibility of utilizing stem cell plasticity for therapeutic purposes. Indeed, stem cells of different origin, such as bone-marrow- and adipose-derived mesenchymal stem cells, circulation-derived progenitor cells, and induced pluripotent stem cells, have all been shown to play therapeutic roles in ischemic heart disease. In addition, the discovery of stem-cell-associated paracrine effects has triggered intense investigations into the actions of exosomes. Notwithstanding the seemingly promising outcomes from both experimental and clinical studies regarding the therapeutic use of stem cells against ischemic heart disease, positive results from fraud or false data interpretation need to be taken into consideration. The current review is aimed at overviewing the therapeutic application of stem cells in different categories of ischemic heart disease, including relevant experimental and clinical outcomes, as well as the proposed mechanisms underpinning such observations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Emergency Medicine, E-Da Hospital, I-Shou University, Kaohsiung City 82445, Taiwan.
- School of Medicine, College of Medicine, I-Shou University, Kaohsiung City 82445, Taiwan.
- Department of Emergency Medicine, E-Da Dachang Hospital, I-Shou University, Kaohsiung City 80794, Taiwan.
ORCID-Profile: Cheuk-Kwan Sun
Zitieren
APA
Tsai, I. T., & Sun, C. K. (2024). Stem Cell Therapy against Ischemic Heart Disease. International Journal of Molecular Sciences, 25(7), 3778. https://doi.org/10.3390/ijms25073778
Vancouver
Tsai IT, Sun CK. Stem Cell Therapy against Ischemic Heart Disease. International Journal of Molecular Sciences. 2024;25(7):3778. doi:10.3390/ijms25073778
BibTeX
@article{Tsai2024,
author = {Tsai, I-Ting and Sun, Cheuk-Kwan},
title = {Stem Cell Therapy against Ischemic Heart Disease},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {7},
pages = {3778},
doi = {10.3390/ijms25073778}
}
EUVIMED